Alpine Immune Sciences to Participate in Two Upcoming Healthcare Conferences
26 Febbraio 2024 - 10:30PM
Business Wire
Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading
clinical-stage immunotherapy company focused on developing
innovative treatments for autoimmune and inflammatory diseases,
today announced that the Company will participate in two upcoming
healthcare conferences.
- Monday, March 4th, Mitchell Gold, M.D., Executive Chairman and
Chief Executive Officer will participate in an IgA Nephropathy
corporate panel at 9:10 am ET/6:10 am PT during the TD Cowen 44th
Annual Healthcare Conference in Boston, MA and the Company will
host investor meetings the same day.
- Tuesday, March 12th, Remy Durand, Ph.D., Chief Business Officer
will participate in a fireside chat during the Leerink Partners
Global Biopharma Conference in Miami, FL at 2:20 pm ET/11:20 am PT
and the Company will host investor meetings the same day.
Live webcasts of the fireside chats will be available in the
investor relations section of the Company’s website at
https://ir.alpineimmunesciences.com/events and a replay will be
available on the Company's website for 90 days following the
event.
About Alpine Immune
Sciences
Alpine Immune Sciences is committed to leading a new wave of
immune therapeutics. With world-class research and development
capabilities, a highly productive scientific platform, and a proven
management team, Alpine is seeking to create first- or
best-in-class multifunctional immunotherapies via unique protein
engineering technologies to improve patients’ lives. Alpine has
entered into strategic collaborations with leading global
biopharmaceutical companies and has a diverse pipeline of clinical
and preclinical candidates in development. For more information,
visit www.alpineimmunesciences.com. Follow @AlpineImmuneSci on X
and LinkedIn.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240226284227/en/
Media and Investor Relations
Contact: ir@alpineimmunesciences.com
media@alpineimmunesciences.com
Grafico Azioni Alpine Immune Sciences (NASDAQ:ALPN)
Storico
Da Dic 2024 a Gen 2025
Grafico Azioni Alpine Immune Sciences (NASDAQ:ALPN)
Storico
Da Gen 2024 a Gen 2025
